Inventor · disambiguated record
Lee Alani Selvey
Also filed as: SELVEY LEE ALANI
18 granted patents·5 pending applications·102 citations·filing 2009–2025
94Inventor score
Top patents by PatentIndex Score
23 records- 0197US11091435B2Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in S1P1 receptor-associated disordersARENA PHARM INC·Filed 2020·Granted Aug 17, 2021·11 cites·15 claims
- 0297US10676435B2Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound 1) for use in SIPI receptor-associated disordersARENA PHARM INC·Filed 2019·Granted Jun 9, 2020·12 cites·25 claims
- 0396US11884626B2Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound1) for use in S1P1 receptor-associated disordersARENA PHARM INC·Filed 2021·Granted Jan 30, 2024·3 cites·16 claims
- 0493US10301262B2Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compund1) for use in SIPI receptor-associated disordersARENA PHARM INC·Filed 2016·Granted May 28, 2019·11 cites·50 claims
- 0592US9353064B2Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related theretoARENA PHARM INC·Filed 2015·Granted May 31, 2016·9 cites·51 claims
- 0691US9034911B2Composition of a 5-HT2A serotonin receptor modulator useful for the treatment of disorders related theretoSELVEY LEE ALANI·Filed 2009·Granted May 19, 2015·27 cites·58 claims
- 0790US12378198B2Crystalline l-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in SIPI receptor-associated disordersARENA PHARM INC·Filed 2023·Granted Aug 5, 2025·0 cites·40 claims
- 0889US2025346560A1Crystalline l-arginine salt of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in sipi receptor-associated disordersARENA PHARM INC·Filed 2025·Application pending·0 cites
- 0988US9745270B2Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related theretoARENA PHARM INC·Filed 2016·Granted Aug 29, 2017·5 cites·8 claims
- 1087US10071075B2Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related theretoARENA PHARM INC·Filed 2017·Granted Sep 11, 2018·4 cites·34 claims
- 1186US11826471B2Compositions comprising PGI2-receptor agonists and processes for the preparation thereofARENA PHARM INC·Filed 2021·Granted Nov 28, 2023·1 cites·25 claims
- 1286US10117851B2Composition of a 5-HT2A serotonin receptor modulator useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2017·Granted Nov 6, 2018·4 cites·22 claims
- 1385US11123298B2Compositions comprising PGI2-receptor agonists and processes for the preparation thereofARENA PHARM INC·Filed 2019·Granted Sep 21, 2021·2 cites·17 claims
- 1485US9801856B2Composition of a 5-HT2A serotonin receptor modulator useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2015·Granted Oct 31, 2017·4 cites·28 claims
- 1584US9126946B2Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related theretoCARLOS MARLON·Filed 2009·Granted Sep 8, 2015·8 cites·66 claims
- 1678US10583122B2Composition of a 5-HT2A serotonin receptor modulator useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2018·Granted Mar 10, 2020·1 cites·27 claims
- 1776US2024285537A1Compositions comprising pgi2-receptor agonists and processes for the preparation thereofARENA PHARM INC·Filed 2023·Application pending·0 cites
- 1875US2022160681A1Composition of a 5-ht2a serotonin receptor modulator useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2021·Application pending·0 cites
- 1972US9192620B2Pharmaceutical compositions comprising forms of 5-azacytidinePHARMION LLC·Filed 2013·Granted Nov 24, 2015·0 cites·17 claims
- 2072US2020138784A1Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related theretoARENA PHARM INC·Filed 2019·Application pending·0 cites
- 2169US2020397753A1Composition of a 5-ht2a serotonin receptor modulator useful for the treatment of disorders related theretoARENA PHARM INC·Filed 2020·Application pending·0 cites
- 2266US10543193B2Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related theretoARENA PHARM INC·Filed 2018·Granted Jan 28, 2020·0 cites·38 claims
- 2361US8975392B2Methods for isolating crystalline form I of 5-azacytidinePHARMION LLC·Filed 2013·Granted Mar 10, 2015·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Lee Alani Selvey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →